Effects of thiazolidinedione in patients with active bladder cancer-Reference-Cited by-同舟云学术

Effects of thiazolidinedione in patients with active bladder cancer

Published:2017-09-23 Issue:2 Volume:121 Page:244-251
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:BJU Int

Author:

Li Roger¹^ORCID,Metcalfe Michael J.¹,Ferguson James E.¹,Mokkapati Sharada¹,Nogueras González Graciela M.²,Dinney Colin P.¹,Navai Neema¹,McConkey David J.³,Sahai Sunil K.⁴,Kamat Ashish M.¹

Affiliation:

1. Department of Urology; The University of Texas MD Anderson Cancer Center; Houston TX USA

2. Department of Biostatistics; The University of Texas MD Anderson Cancer Center; Houston TX USA

3. Department of Urology; The James Buchanan Brady Urological Institute; Johns Hopkins University School of Medicine; Baltimore MD USA

4. Department of General Internal Medicine; The University of Texas MD Anderson Cancer Center; Houston TX USA

Funder

Cancer Center Support

Bladder SPORE (Specialized Program of Research Excellence)

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bju.14009/fullpdf

Reference18 articles.

1. Urothelial carcinogenesis in the urinary bladder of male rats treated with muraglitazar, a PPAR alpha/gamma agonist: evidence for urolithiasis as the inciting event in the mode of action;Dominick;Toxicol Pathol,2006

2. Rosiglitazone, a PPAR gamma agonist: potent promoter of hydroxybutyl(butyl)nitrosamine-induced urinary bladder cancers;Lubet;Int J Cancer,2008

3. Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial;Dormandy;Lancet,2005

4. Risk of bladder cancer among diabetic patients treated with pioglitazone: interim report of a longitudinal cohort study;Lewis;Diabetes Care,2011

5. Ten-year observational follow-up of PROactive: a randomized cardiovascular outcomes trial evaluating pioglitazone in type 2 diabetes;Erdmann;Diabetes Obes Metab,2016

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. KIF4A promotes the development of bladder cancer by transcriptionally activating the expression of CDCA3;International Journal of Molecular Medicine;2021-04-09

2. DPP4i, thiazolidinediones, or insulin and risks of cancer in patients with type 2 diabetes mellitus on metformin–sulfonylurea dual therapy with inadequate control;BMJ Open Diabetes Research & Care;2020-06

3. Pioglitazone Alters the Proteomes of Normal Bladder Epithelial Cells but Shows No Tumorigenic Effects;International Neurourology Journal;2020-03-31